188 results about "Lipoic acid" patented technology

The invention belongs to the technical field of adhesives, and particularly relates to a preparation method of a polysaccharide-based reversible bonding adhesive for constructing a dynamic covalent bond network. The preparation method comprises the following steps: by taking lipoic acid and sodium alginate as reactants and ferric chloride as a cross-linking agent, carrying out cross-linking reaction under a stirring condition to obtain a lipoic acid adhesive, namely the polysaccharide-based reversible bonding adhesive. According to the invention, renewable biomass resources such as sodium alginate, hyaluronic acid, chitosan and the like are used as main raw materials, so that the adhesive is expected to replace a traditional synthetic adhesive depending on a petroleum base, accords with a sustainable development strategy, contributes to reducing consumption of fossil resources, avoids release of toxic substances such as formaldehyde and the like in the synthesis and use processes, and has a good application prospect. And the method is more environment-friendly. The bio-based polysaccharide raw material has good biocompatibility and degradability, and an ideal base material is provided for developing a green and safe biomedical adhesive.

The invention relates to a method for preparing small-particle-size red nano-selenium particles and application of the small-particle-size red nano-selenium particles, and belongs to the technical field of selenium compounds. The nano-selenium particles contain nano-selenium and a lipoic acid oligomer. The preparation method comprises the following steps: respectively preparing nano-selenium and a lipoic acid oligomer, and uniformly mixing the nano-selenium and the lipoic acid oligomer to obtain the nano-selenium particles. The nano-selenium particles have good stability; the content of total protein and fat in highland barley grains to which the nano-selenium particles are applied is remarkably increased through detection, the nano-selenium particles become an effective means for selenium enrichment of crops, the nano-selenium particles are well applied to selenium-enriched planting of highland barley, and the application of the nano-selenium particles to the highland barley grains is developed by combining development of new selenium-enriched crop varieties and research of a new selenium fertilizer application technology. And a powerful promotion effect is achieved on the development of selenium-enriched ecological agriculture.

The invention relates to an anti-aging capsule compounded by PQQ and mitochondrial nutrients, and discloses an anti-aging capsule which is prepared by synergistically compounding a plurality of mitochondrial nutrients according to a scientific proportion and supplementing high-purity raw materials and slow-release dosage forms to realize energy metabolism activation and anti-oxidation synergistic intervention. Therefore, the anti-aging capsule systematically delays aging through multi-target regulation and control of mitochondrial functions. The capsule is characterized by comprising the following components in parts by weight: 1-20 mg of pyrroloquinoline quinone disodium salt (PQQ), 20-100 mg of coenzyme Q10, 50-200 mg of L-carnitine tartrate, 10-100 mg of alpha-lipoic acid, 50-300 mg of nicotinamide mononucleotide (NMN) or nicotinamide nucleoside (NR), and 10-50 [mu] g of selenoprotein or organic selenium yeast, and a capsule carrier comprises 100 mg of gelatin or a plant-derived capsule shell, 180 mg of microcrystalline cellulose, 5 mg of magnesium stearate and 5 mg of silicon dioxide.

The invention designs a high-performance lipoic acid-based biomass adhesive as well as a preparation method and application thereof, and belongs to the field of bio-based adhesives in high polymer materials. The lipoic acid-based biomass adhesive disclosed by the invention is a light yellow solid and comprises the following raw material components: lipoic acid, a modifying reagent 1 and a modifying reagent 2. The preparation method of the lipoic acid-based biomass adhesive comprises the following steps: dissolving lipoic acid in a proper amount of an organic solvent, adding a modifying reagent 1, uniformly stirring, adding a catalyst 1, and reacting at a certain temperature; and adding a modifying reagent 2 and a catalyst 2 to react to obtain the lipoic acid bio-based adhesive. The lipoic acid-based biomass adhesive disclosed by the invention has the characteristics of environment friendliness, degradability, high bonding strength, convenience in bonding, recyclability, repeated use, complex environment bonding resistance and the like.

Methods, kits fand photothermal compositions for removing nail coatings are described. The nail coatings include a thermally responsive material, such as thermally expandable microspheres, and a nail product to be removed (e.g. nail polish, gel, dip, nail art, and / or artificial nail. Optionally, a bottom coating, such as lipoic acid, is in contact with the nail surface. The method includes (ii) applying a removal stimulus to a removal layer containing a photothermal additive to induce heat generation and cause at least partial expansion, shape change, and / or phase change of the thermally responsive material or partial detachment of the nail product. Optionally the method includes applying the photothermal nail composition on top of a nail coating prior to step (ii).

An orally administered composition for treating or reducing damage to connective tissue or for treating or reducing inflammatory symptoms associated with damage to connective tissue includes a synergistic combination of (i) avocado / soybean unsaponifiables; and (ii) a lipoic acid or a salt or derivative thereof. A method for treating or reducing damage to connective tissue, for treating or reducing inflammatory symptoms associated with damage to connective tissue, or for reducing the level of one or more inflammatory mediators in connective tissue includes administering the orally administered composition to an avian or mammalian subject.

A complex consisting of lipoic acid or a salt thereof, a chelating agent such as a salt of ethylene diamine tetraacetic acid (EDTA) or analogous compounds and an ester of ascorbic acid with long-chain fatty acids, in particular ascorbyl palmitate inhibits the pigmentation of teeth induced by chlorhexidine and salts thereof. In addition to the depigmenting complex, the formulations of the invention, in the form of gels, mouthwashes, toothpastes or periodontal sprays, may contain other ingredients such as hyaluronic acid or hyaluronates, glycerophosphocholine, sweeteners, flavourings, buffering agents, viscosifying agents, mucoadhesive and filming agents, solvents, co-solvents, surfactants.

This invention relates to a juglansin and lipoic acid conjugate, its preparation method, and its applications. The juglansin and lipoic acid conjugate is named CL-1. CL-1 exhibits significant protective effects in models of oxidative and inflammatory damage in nerve cells, with a significantly greater reduction in TNF-α and IL-6 levels than the monomeric juglansin and lipoic acid, indicating that CL-1 has superior anti-inflammatory and anti-neural damage effects compared to the monomeric drugs, and possesses the potential to treat neurodegenerative diseases such as Alzheimer's disease. The provided preparation method is designed specifically for the structural characteristics of juglansin and lipoic acid, enabling efficient and large-scale synthesis of CL-1.

The application provides a kind of mitochondrial function optimization additive for cell culture, preparation method and application, belongs to cell culture technical field.The additive includes core active ingredient, auxiliary component and carrier, and the core active ingredient includes D-Arg-Cha-Lys-Phe-NH2 Polypeptide, ubiquinone-10 phosphate, reduced glutathione and alpha-lipoic acid.The application forms a multi-target core active system through the synergy of the four, realizes the triple synergistic protection of stabilizing mitochondrial cardiolipin, maintaining mitochondrial morphology and membrane potential, and reducing mitochondrial ROS, which can significantly improve cell culture quality.When applied, the mitochondrial cardiolipin content can be increased by more than 50%, the mitochondrial abnormality ratio can be reduced to less than 12%, the membrane potential positive cell ratio can be increased to more than 86%, the mitochondrial ROS level can be reduced by more than 40%, and the cell proliferation rate can be increased by more than 25%, which is suitable for in vitro culture of various eukaryotic cells, and the preparation process is simple and has no cytotoxicity.

The invention discloses an instant plugging agent as well as a preparation method and application thereof, and belongs to the technical field of biological materials. The instant plugging agent comprises a solution A and a solution B, wherein the solution A is an organic solution containing lipoic acid; the solution B is an aqueous solution containing metal ions. The preparation method comprises the following steps: dissolving lipoic acid in an organic solvent to prepare a solution A; dissolving salt of metal ions in water to prepare a solution B; the application refers to the application in preparation of products for stopping bleeding of human bodies or animal bodies and / or sealing tissue defects. The plugging agent has the characteristic of instant curing, and can tolerate bursting pressure exceeding 450 mm Hg; the device is not only suitable for general wound errhysis, but also can effectively deal with acute hemorrhage and emergency plugging of tissue defects in high-pressure and high-flow-rate states.

The invention provides an anti-cancer medicine and food homologous composition and a preparation method thereof. The composition is prepared from the following components in parts by weight: 5 to 10 parts of lipoic acid, 30 to 50 parts of nano curcumin, 2 to 7 parts of berberine, 50 to 100 parts of beta-glucan, 15 to 35 parts of polymethylacrylic acid, 15 to 25 parts of herba hedyotidis diffusae extract, 7 to 15 parts of scutellaria barbata baicalein, 25 to 55 parts of astragalus polysaccharide, 8 to 18 parts of coix seed ester and 10 to 15 parts of cordyceps cicadae. Through a space-time targeting synergistic release mechanism of a bionic nanocellulose skeleton and in combination with pH / enzyme double-response intelligent regulation and control, three-stage precise synergistic effects of oxidation resistance, apoptosis promotion and immune activation are realized, the limitation that a traditional medicinal and edible composition is poor in targeting property, low in synergistic efficiency and uncontrollable in toxicity is broken through, and the medicinal and edible composition has a broad application prospect. High-efficiency and low-toxicity tumor multi-channel synergistic intervention is achieved in a natural component system for the first time, and the actual effect of the whole medicinal and edible composition on cancer and swelling resistance is improved.

The invention relates to the technical field of biological medicines, and discloses an application of N2L in preparation of medicines for preventing and treating obesity and fatty liver, and the N2L is a dimer compound of alpha-lipoic acid and nicotinic acid. According to the embodiment of the invention, the application value of the GPR109A and GLP-1R double-target collaborative strategy in obesity and fatty liver treatment is proposed and verified for the first time, and the small molecule compound N2L with the GPR109A and GLP-1R double-target collaborative strategy can improve muscle endurance while reducing the weight of obese patients and can improve liver fatty degeneration at the same time. The defect that an existing GLP-1R agonist needs to be injected is overcome, meanwhile, the flushing side effect of an existing GPR109A agonist nicotinic acid medicine is avoided, a larger range is provided for medicine selection in the fields of obesity and fatty liver, and meanwhile, the application range of N2L is widened.

This invention discloses a cationic lipid molecule based on lipoic acid derivatives for mRNA delivery, its preparation method, and its uses. The cationic lipid molecule is prepared by reacting lipoic acid with a hydrophilic amine, wherein the hydrophilic amine is one of 4A1, 5A1, or 6A2. The cationic lipid molecule synthesized in this invention contains a protonated nitrogen atom that can bind to negatively charged nucleic acids and form highly stable nanoparticles with polyethyleneimine (PEI), thus improving nucleic acid loading and demonstrating its excellent application in mRNA delivery.

The invention discloses a preparation method and application of organic-inorganic composite hydrogel with high mechanical adaptability and wet adhesion stability, and belongs to the technical field of biomedical tissue engineering. The hydrogel is prepared from the following components in percentage by mass: 8.125 percent to 65 percent of calcium phosphate and 35 percent to 91.875 percent of lipoic acid. The bionic wound dressing is beneficial to proliferation and migration of fibroblasts, and more ideal soft tissue regeneration is realized. Experimental results prove that the suture has good cytocompatibility, can quickly promote rat skin defect repair (20 + / -1mm limit skin injury repair time is shortened to 2 weeks), and has a more remarkable healing effect compared with a contrast traditional suture and gauze with an optimal clinical repair effect. The organic-inorganic composite hydrogel with high mechanical adaptability and wet adhesion stability prepared by the invention shows good mechanical properties, also has excellent adhesion, and is beneficial to soft tissue repair.

The application discloses application of a lipoic acid analogue in preparation of a product for relieving myocardial cell hypertrophy, and the lipoic acid analogue DMAE-LA is N -(2-(dimethylamino)ethyl)-5-(1,2-dithiopentyl-3-yl)valeric amide. DMAE-LA can effectively reduce ISO-induced myocardial hypertrophy of mice, reduce heart weight index and ANP and BNP expression, and significantly improve heart function. A small dose (2-10 μM) of a lysosome-targeting lipoic acid analogue DMAE-LA can effectively improve Ang II-induced myocardial hypertrophy and oxidative stress in H9c2 cells, and the protective effect is better than that of a high dose (200-400 μM) of LA. As a new substitute of traditional LA, DMAE-LA shows great potential for prevention and treatment of cardiovascular diseases.

This invention relates to the field of adhesive technology, and discloses an environmentally friendly biomass-based underwater adhesive, its preparation method, and its applications. The adhesive is prepared by one-step melt copolymerization of three biomass raw materials: lipoic acid, caffeic acid, and cysteine. This system utilizes the ring-opening polymerization of lipoic acid to form a dynamic disulfide bond network providing cohesive force, the catechol groups of caffeic acid to provide various interfacial interactions with the substrate, and the thiol groups of cysteine ​​to simultaneously participate in network construction and inhibit catechol oxidation, thereby synergistically achieving high-strength and durable underwater adhesion. The adhesive achieves an underwater adhesion strength of up to 5.5 MPa on iron sheets, remains stable in various acid, alkali, and salt environments, and can be repeatedly recycled through hot melting. This invention uses entirely bio-based raw materials, employs a simple and non-toxic process, and is suitable for underwater remediation, marine engineering, and other fields.

The application provides a kind of mitochondrial function optimization additive for cell culture, preparation method and application, belong to cell culture technical field.The additive includes core active ingredient, auxiliary component and carrier, and the core active ingredient includes D-Arg-Cha-Lys-Phe-NH2 Polypeptide, ubiquinone-10 phosphate, reduced glutathione and alpha-lipoic acid.The application forms a multi-target core active system through the synergy of the four, realizes the triple synergistic protection of stabilizing mitochondrial cardiolipin, maintaining mitochondrial morphology and membrane potential, and reducing mitochondrial ROS, which can significantly improve cell culture quality.When applied, the mitochondrial cardiolipin content can be increased by more than 50%, the mitochondrial abnormality ratio can be reduced to less than 12%, the membrane potential positive cell ratio can be increased to more than 86%, the mitochondrial ROS level can be reduced by more than 40%, and the cell proliferation rate can be increased by more than 25%, which is suitable for in vitro culture of various eukaryotic cells, and the preparation process is simple and has no cytotoxicity.

The invention provides an organic solar cell acceptor material containing a lipoic acid group as well as a preparation method and application of the organic solar cell acceptor material. The chemical structural formula of the acceptor material is shown in the specification, AK is selected from one of a saturated alkyl chain, an ether chain or a siloxane chain with the carbon atom number of 1-20, and X and Y are independently selected from H, I, F or Cl respectively. According to the invention, the crosslinking group lipoic acid is introduced into the organic solar cell acceptor material for the first time, and the disulfide bond of the organic solar cell acceptor material can realize dynamic ring opening under the conditions of ultraviolet irradiation and heating; therefore, the material can improve the microstructure of an active layer film in an organic solar cell device, improve the stability of a photovoltaic device and enhance the mechanical property of the device, so that the balance problem between the mechanical durability and the photoelectric property of the photovoltaic device is improved.

This invention relates to the field of biomedical technology and discloses an amphiphilic nicotinamide adenine dinucleotide (NAD) + Couplings, nanomicelles and their applications. Amphiphilic NAD+ + Couplings have the following general structural formula: ; where NAD + R is a hydrophilic group, R is a hydrophobic antioxidant group, and phenylboronic acid derivative is the linking bond; R is selected from free radical scavengers, small molecule organoselenic compounds that mimic the function of glutathione peroxidase 4, iron chelating agents, 7-dehydrocholesterol, royal jelly acid, α-lipoic acid, oleic acid, or derivatives of the above molecules. In this invention, NAD... + Conjugates and their self-assembled nanomicelles possess functions such as promoting DNA repair, maintaining cellular homeostasis, and delaying aging. Simultaneously, nanomicelles can inhibit inflammation and oxidative stress, and can physically encapsulate hydrophobic active drugs, showing broad application prospects in inflammatory diseases, age-related diseases, organ damage, and the prevention and treatment of toxic side effects from chemotherapy drugs.

This invention discloses the application of lipoic acid analog formulations in the preparation of anti-cardiomyocyte senescence products. The lipoic acid analog DMAE-LA is N-(2-(dimethylamino)ethyl)-5-(1,2-dithiopentane-3-yl)pentanamide, with a concentration of 2-25 μM. DMAE-LA pretreatment effectively reduces intracellular ROS, improves mitochondrial function, inhibits the overexpression of p21 and HMGB1, and restores Lamin B1 levels, thereby alleviating the senescent manifestations of cardiomyocytes. DMAE-LA reduces H₂S oxidative depletion by inhibiting ROS generation and may promote H₂S synthase activity, increasing endogenous H₂S levels and further enhancing cellular antioxidant capacity. In summary, DMAE-LA can significantly inhibit cardiomyocyte senescence through multiple antioxidant mechanisms and organelle function protection, providing a potential intervention strategy for targeting cellular senescence in cardiovascular diseases.

The invention provides a method for detecting a polymer in a lipoic acid injection, which adopts a liquid chromatography-mass spectrometry detection method to qualitatively detect and analyze the impurities of the polymer in the lipoic acid injection, and adopts a high performance liquid chromatography to quantitatively detect and analyze the impurities of the polymer and quantitatively confirm the impurities of the polymer through nuclear magnetism. According to the detection method disclosed by the invention, polymer impurities, including lipoic acid and at least seven common impurities, in the lipoic acid injection can be separated in a high performance liquid chromatogram and are quantitatively determined; the method is high in accuracy, good in specificity, high in analysis speed, stable in linear relation and good in reproducibility, qualitative and quantitative quality detection and monitoring of the lipoic acid injection are facilitated, stable quality and safety of the lipoic acid injection are guaranteed, and application and popularization are facilitated.

The invention discloses an anticorrosive coating as well as a preparation method and application thereof, and relates to the technical field of high polymer materials and metal corrosion protection. The anticorrosive paint comprises the following components which are independently subpackaged: a component A: an epoxy resin prepolymer; component B: an epoxy resin curing agent, wherein the epoxy resin curing agent comprises an amino curing agent; component C: a functional molecule, wherein the functional molecule comprises alpha-lipoic acid. The coating has an innovative self-layering structure, so that the coating has a lotus leaf effect-like hydrophobic surface and super glue-like base layer adhesion at the same time, and the contradiction that the hydrophobicity and the adhesion force of a traditional coating are difficult to consider at the same time is solved. The existence of the dynamic disulfide bond not only endows intelligent release and potential self-repairing functions, but also provides possibility for degradation and chemical recovery of the coating material after the life cycle is ended, and conforms to the concepts of green chemistry and sustainable development.

The application discloses a novel ginsenoside sulfur-containing derivative and a preparation method and application thereof, and belongs to the technical field of medicines. The ginsenoside sulfur-containing derivative is synthesized by using oktillone type ginsenoside and alpha-lipoic acid as raw materials, selecting DCC and EDCI as condensing agents, and selecting DMAP as a catalyst, and a protection effect on liver injury is researched. In-vivo and in-vitro experimental results show that the effect of the ginsenoside sulfur-containing derivative is significantly better than that of oktillone and other ginsenosides and other drugs, and the ginsenoside sulfur-containing derivative opens up a new direction for the development of anti-liver injury drugs.

The invention relates to the technical field of materials for preventing and treating local infection, in particular to drug-loaded composite nanoparticles as well as a preparation method and application thereof. The drug-loaded composite nanoparticles provided by the invention comprise hollow polydopamine grafted with vancomycin and lipoic acid-quaternary ammonium salt ionic liquid loaded into a cavity of the hollow polydopamine. In the invention, the HPDA nanoparticles have a hollow structure, and the structure provides sufficient space for loading of drug molecules. The lipoic acid-quaternary ammonium salt ionic liquid can generate heat energy under the microwave heat effect, and bacteria are effectively killed. Besides, under microwave stimulation, the lipoic acid-quaternary ammonium salt ionic liquid not only can enhance the sterilization effect, but also can reduce inflammatory response caused by bacterial infection through the synergistic effect of microwave heat effect and chemical sterilization.

The invention relates to an formulation for cardiac support supplements and the method of its preparation by using molecular-level mixing technology. The method involves preparing molecular-level emulsions of alpha-lipoic acid, acetyl L-carnitine, and coenzyme Q10, followed by spray drying to produce a homogeneous powder premix. This approach ensures precise dosage control, enhanced bioavailability, and improved stability, making it a valuable advancement in the field of nutraceutical and pharmaceutical formulations.

Disclosed is a method for forming selenoneine or analogs thereof. The method may include phosphorylating sodium selenide to a selenophosphate, using adenosine triphosphate (ATP) and at least a first protein, generating a selenosugar by converting the selenophosphate using at least a second protein in the presence of a common sugar donor, and forming selenoneine or an analog thereof by combining the selenosugar with N,N,N-trimethyl-L- histidine or analogs thereof using at least a third protein. The method may include combining SenA, SenB, and SenC in an aqueous buffer at neutral pH and ambient temperature, and allowing SenA, SenB, and SenC to form selenoneine or an analog thereof in the presence of ATP, a common sugar donor, and sodium selenide.

The application provides an immune cell culture kit, a culture method and application of gamma delta T cells, and the kit comprises a basic culture medium, a recombinant antibody, a cytokine and a cell proliferation promoting additive, the basic culture medium comprises an RPMI-1640 culture medium, and the cell proliferation promoting additive comprises 1-thioglycerol, taurine, beta-cyclodextrin, thymidine, alpha-lipoic acid, beta-mercaptoethanol and bisphosphonate. The gamma delta T cells obtained by the culture kit have high purity and activity, and have good tumor killing activity. The gamma delta T cells obtained by the method have a high positive rate of 100% of perforin expression.

The application relates to the technical field of toothpaste, and discloses toothpaste with antibacterial and bacteriostatic effects and a preparation method thereof. The toothpaste is prepared from bacteriostatic paste base, silicon dioxide, titanium dioxide, sodium lauryl sulfate, sodium saccharin and peppermint essence. The bacteriostatic paste base is prepared from deionized water, sorbitol aqueous solution, sodium carboxymethyl cellulose, alpha-lipoic acid powder, sodium hydroxide aqueous solution and zinc sulfate aqueous solution. The toothpaste has good bacteriostatic performance.

The invention relates to a preparation method of 1-(5-[1, 2] dithiolane-3-yl valeryl) pyrrolidine-2, 5-diketone, a reaction equation is as follows: the preparation method comprises the following steps: S1, adding pyrrolidine-2, 5-diketone, alpha-lipoic acid and a solvent into a microwave reaction bottle, and stirring to form a solution I; s2, adding a coupling agent and a catalyst into the solution I, and stirring to form a solution II; and S3, placing the microwave reaction bottle filled with the solution II in a microwave reactor for reaction, and performing post-treatment to obtain the 1-(5-[1, 2] dithiolane-3-yl valeryl) pyrrolidine-2, 5-diketone. According to the microwave method preparation process adopted by the invention, the reaction efficiency of the preparation process of the 1-(5-[1, 2] dithiolane-3-yl valeryl) pyrrolidine-2, 5-diketone is greatly improved, and the yield and the purity of the product are greatly improved.